Upgrade to Straedigm Flow Cytometer

The Food and Drug Administration intends to make a sole source award for upgrades to our Stratedigm S1000. The FDAs/Center for Drug Evaluation and Research (CDER) uses flow cytometry as a method to evaluate many different cell parameters as part of laboratory research. We currently have an S-1000 model flow cytometer that can measure 13-color parameters per cell. The action is to upgrade the existing system to measure 24 color parameters per cell.
We intend to make a sole source award for this upgrade to:

Stratedigm, Inc.
6541 Via Del Oro, Suite A
San Jose, CA 95119

In accordance with FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements.

This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement within five (5) days after the publication of this synopsis which shall be considered by the agency. Responses received after 5 days or without the required information may not be considered. For information concerning this acquisition contact:

Susan Bechtel
Contract Specialist
Susan.Bechtel@fda.hhs.gov
No phone calls please

A determination by the Government not to compete because of information received is solely within the discretion of the Government. Information received will normally be considered solely for determining whether to conduct a competitive procurement.

.